Ethical considerations of phone-based interviews from three studies of COVID-19 impact in Bihar, India.

Phone-based interviews present a range of ethical challenges, including how to ensure informed consent and privacy and maintain confidentiality. Our paper presents conceptual and practical ethical considerations taken into account across three telephone studies on the impact of COVID-19 conducted following India's nationwide lockdown imposed in March 2020. Two studies captured COVID-19 response impact on primary-level Reproductive Maternal Neonatal and Child Health (RMNCH) services and on provider wellness, respectively. The third study focused on how the gendered experience of COVID-19 and the state's response to control transmission impacted women's lives, focusing on health services, livelihood, entitlements and social change, by interviewing individual women. The ethical challenges as well as the advantages of digital data collection are presented with recommendations for low-resource settings. Ethical considerations included the above challenges as well as avoiding posing unreasonable time burden on the respondents, framing questions with a gendered lens, considering emotional states given contagion concerns and economic uncertainties, and redressing pandemic-induced distress. Using scripted Hindi was challenging in consent-taking, as was protecting household respondents' privacy and confidentiality during lockdown. Unanticipated positive ethical implications of using a telephone approach included providing respondents privacy and catharsis, respondents choosing convenient interview times and affording health providers more privacy than institutional inperson interviews. Internalising empathy, respect and appreciative enquiry are key to establishing rapport in the absence of prior relationships. Institutional Review Board (IRB) time limits on call duration need to be flexible to allow for 'active listening' and empathetic enquiry in surveys on the impact of COVID-19.

Impacts of partial to complete COVID-19 lockdown on NO2 and PM2.5 levels in major urban cities of Europe and USA.

SARS CoV-2 (COVID-19) coronavirus has been causing enormous suffering, death, and economic losses worldwide. There are rigorous containment measures on industries, non-essential business, transportation, and citizen mobility to check the spread. The lockdowns may have an advantageous impact on reducing the atmospheric pollutants. This study has analyzed the change in atmospheric pollutants, based on the Sentinel-5Ps and ground-station observed data during partial to complete lockdown period in 2020. Results revealed that the mean tropospheric NO2 concentration substantially dropped in 2020 due to lockdown against the same period in 2019 by 18-40% over the major urban areas located in Europe (i.e. Madrid, Milan, Paris) and the USA (i.e. New York, Boston, and Springfield). Conversely, urban areas with partial to no lockdown measures (i.e. Warsaw, Pierre, Bismarck, and Lincoln) exhibited a relatively lower dropdown in mean NO2 concentration (3 to 7.5%). The role of meteorological variability was found to be negligible. Nevertheless, the reduced levels of atmospheric pollutants were primarily attributed to the shutdown of vehicles, power plants, and industrial emissions. Improvement in air quality during COVID-19 may be temporary, but regulatory bodies should learn to reduce air pollution on a long-term basis concerning the trade-offs between the environment, society, and economic growth. The intersection of urban design, health, and environment should be addressed by policy-makers to protect public health and sustainable urban policies could be adopted to build urban resilience against any future emergencies.

Pandemic response in pluralistic health systems: a cross-sectional study of COVID-19 knowledge and practices among informal and formal primary care providers in Bihar, India.

OBJECTIVES: Responding to pandemics is challenging in pluralistic health systems. This study assesses COVID-19 knowledge and case management of informal providers (IPs), trained practitioners of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy (AYUSH) and Bachelor of Medicine, Bachelor of Surgery (MBBS) medical doctors providing primary care services in rural Bihar, India. DESIGN: This was a cross-sectional study of primary care providers conducted via telephone between 1 and 15 July 2020. SETTING: Primary care providers from 224 villages in 34 districts across Bihar, India. PARTICIPANTS: 452 IPs, 57 AYUSH practitioners and 38 doctors (including 23 government doctors) were interviewed from a census of 1138 primary care providers used by community members that could be reached by telephone. PRIMARY OUTCOME MEASURES: Providers were interviewed using a structured questionnaire with choice-based answers to gather information on (1) change in patient care seeking, (2) source of COVID-19 information, (3) knowledge on COVID-19 spread, symptoms and methods for prevention and (4) clinical management of COVID-19. RESULTS: During the early days of the COVID-19 pandemic, 72% of providers reported a decrease in patient visits. Most IPs and other private primary care providers reported receiving no COVID-19 related engagement with government or civil society agencies. For them, the principal source of COVID-19 information was television and newspapers. IPs had reasonably good knowledge of typical COVID-19 symptoms and prevention, and at levels similar to doctors. However, there was low stated compliance among IPs (16%) and qualified primary care providers (15% of MBBS doctors and 12% of AYUSH practitioners) with all WHO recommended management practices for suspect COVID-19 cases. Nearly half of IPs and other providers intended to treat COVID-19 suspects without referral. CONCLUSIONS: Poor management practices of COVID-19 suspects by rural primary care providers weakens government pandemic control efforts. Government action of providing information to IPs, as well as engaging them in contact tracing or public health messaging can strengthen pandemic control efforts.

Structure-Based Virtual Screening to Discover Potential Lead Molecules for the SARS-CoV-2 Main Protease.

The COVID-19 disease is caused by a new strain of the coronavirus family (SARS-CoV-2), and it has affected at present millions of people all over the world. The indispensable role of the main protease (Mpro) in viral replication and gene expression makes this enzyme an attractive drug target. Therefore, inhibition of SARS-CoV-2 Mpro as a proposition to halt virus ingression is being pursued by scientists globally. Here we carried out a study with two objectives: the first being to perform comparative protein sequence and 3D structural analysis to understand the effect of 12 point mutations on the active site. Among these, two mutations, viz., Ser46 and Phe134, were found to cause a significant change at the active sites of SARS-CoV-2. The Ser46 mutation present at the entrance of the S5 subpocket of SARS-CoV-2 increases the contribution of other two hydrophilic residues, while the Phe134 mutation, present in the catalytic cysteine loop, can cause an increase in catalytic efficiency of Mpro by facilitating fast proton transfer from the Cys145 to His41 residue. It was observed that active site remained conserved among Mpro of both SARS-CoVs, except at the entrance of the S5 subpocket, suggesting sustenance of substrate specificity. The second objective was to screen the inhibitory effects of three different data sets (natural products, coronaviruses main protease inhibitors, and FDA-approved drugs) using a structure-based virtual screening approach. A total of 73 hits had a combo score >2.0. Eight different structural scaffold classes were identified, such as one/two tetrahydropyran ring(s), dipeptide/tripeptide/oligopeptide, large (approximately 20 atoms) cyclic peptide, and miscellaneous. The screened hits showed key interactions with subpockets of the active site. Further, molecular dynamics studies of selected screened compounds confirmed their perfect fitting into the subpockets of the active site. This study suggests promising structures that can fit into the SARS-CoV-2 Mpro active site and also offers direction for further lead optimization and rational drug design.

Estimating the Prevalence of Anxiety Disorder in COVID 19 Patients-A Cross Sectional Study

Previous studies have shown a broad range of mental disorders including Anxiety and PTSD during SARS epidemic in 2003 and MERS epidemic in 2015. However, recently published researches on psychological impact of COVID-19 mainly focus on the healthcare workers and general public. Very few studies have established effect of COVID-19 epidemic on mental health of the hospitalized patients with COVID-19. In the present study, we aimed to evaluate mental health outcomes among patients with COVID-19 by quantifying the magnitude of symptoms of anxiety and by analyzing potential risk factors associated with these symptoms. This study may assist doctors to provide more appropriate treatment and psychological interventions to improve mental and physical health of patients during the campaign to contain COVID-19 pandemic.